enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications

Biotechnology

enGene

enGene's headquarters in Montréal, Canada

The Boston office focuses on regulatory affairs, talent acquisition, human resources, and research within biotechnology and pharmaceuticals.

People (0)

Jobs (0)

Other offices